University of Kansas Hospital Cambridge North Tower A is a clinical research site located in Kansas City, Kansas, United States 66160.
Crixeo Clinical Trials Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.
University of Kansas Hospital Cambridge North Tower A has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: Diffuse Large B-Cell Lymphoma, Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck.
Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Kansas · View every site in Kansas City
Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Kansas Hospital Cambridge North Tower A has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Kansas Hospital Cambridge North Tower A has 3 clinical trials on record, with 2 currently active. Their work covers Diffuse Large B-Cell Lymphoma, Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck.
University of Kansas Hospital Cambridge North Tower A has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.